| 000 | 01069 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250514021239.0 | ||
| 264 | 0 | _c20020513 | |
| 008 | 200205s 0 0 eng d | ||
| 022 | _a0363-9045 | ||
| 024 | 7 |
_a10.1081/ddc-100107682 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWang, D P | |
| 245 | 0 | 0 |
_aStability of 4-DMAP in solution. _h[electronic resource] |
| 260 |
_bDrug development and industrial pharmacy _cOct 2001 |
||
| 300 |
_a997-1001 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_a4-Aminopyridine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aAntidotes _xchemistry |
| 650 | 0 | 4 | _aBuffers |
| 650 | 0 | 4 | _aChromatography, High Pressure Liquid |
| 650 | 0 | 4 | _aDrug Stability |
| 650 | 0 | 4 | _aHydrogen-Ion Concentration |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 | _aSolvents |
| 650 | 0 | 4 | _aTemperature |
| 700 | 1 | _aChang, L C | |
| 700 | 1 | _aWang, M T | |
| 773 | 0 |
_tDrug development and industrial pharmacy _gvol. 27 _gno. 9 _gp. 997-1001 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1081/ddc-100107682 _zAvailable from publisher's website |
| 999 |
_c11675593 _d11675593 |
||